Evidence map›Paper›PMID 36145077›Full record

ReviewNutrients2022

Role of Postbiotics in Diet-Induced Metabolic Disorders.

Miri Park, Minji Joung, Jae-Ho Park, Sang Keun Ha, Ho-Young Park

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Incorporating Postbiotics into Intervention for Managing Obesity.International journal of molecular sciences · 2025
    Review
  14. Yogurt in Combination with InactivatedAnimals : an open access journal from MDPI · 2025
    Article
  15. Review
  16. Review
  17. Review
  18. Postbiotics as Metabolites and Their Biotherapeutic Potential.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Miri ParkFood Functionality Research Division, Korea Food Research Institute, Wanju 55365, Korea.
Minji JoungFood Functionality Research Division, Korea Food Research Institute, Wanju 55365, Korea.
Jae-Ho ParkFood Functionality Research Division, Korea Food Research Institute, Wanju 55365, Korea.ORCID 0000-0003-4428-436X
Sang Keun HaFood Functionality Research Division, Korea Food Research Institute, Wanju 55365, Korea.ORCID 0000-0002-3329-2279
Ho-Young ParkFood Functionality Research Division, Korea Food Research Institute, Wanju 55365, Korea.ORCID 0000-0002-9966-9059
Korea Food Research Institute · KR

Funding

Korea Food Research Institute E0210602-02
6 · The paper itself

Abstract

Although the prevalence of metabolic disorders has progressively increased over the past few decades, metabolic disorders can only be effectively treated with calorie restriction and improved physical activity. Recent research has focused on altering the gut microbiome using prebiotics, probiotics, and postbiotics because various metabolic syndromes are caused by gut microbial dysbiosis. Postbiotics, substances produced or released by microorganism metabolic activities, play an important role in maintaining and restoring host health. Because postbiotics have a small amount of literature on their consumption, there is a need for more experiments on short- and long-term intake. This review discusses current postbiotic research, categories of postbiotics, positive roles in metabolic syndromes, and potential therapeutic applications. It covers postbiotic pleiotropic benefits, such as anti-obesity, anti-diabetic, and anti-hypertensive qualities, that could aid in the management of metabolic disorders. Postbiotics are promising tools for developing health benefits and therapeutic goals owing to their clinical, technical, and economic properties. Postbiotic use is attractive for altering the microbiota; however, further studies are needed to determine efficacy and safety.

Indexed as

Metabolic DiseasesMetabolic SyndromeProbioticsAntihypertensive AgentsDietDysbiosisHumansPrebioticsAntihypertensive AgentsPrebioticsgut microbiotametabolic disordermetaboliteparabioticpostbiotic

Identifiers

PMID36145077
PMCPMC9503758
OpenAlexW4296113983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.